1. Home
  2. ZJYL vs ADVM Comparison

ZJYL vs ADVM Comparison

Compare ZJYL & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZJYL
  • ADVM
  • Stock Information
  • Founded
  • ZJYL 2006
  • ADVM 2006
  • Country
  • ZJYL China
  • ADVM United States
  • Employees
  • ZJYL N/A
  • ADVM N/A
  • Industry
  • ZJYL Industrial Specialties
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZJYL Consumer Discretionary
  • ADVM Health Care
  • Exchange
  • ZJYL Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • ZJYL 111.3M
  • ADVM 94.6M
  • IPO Year
  • ZJYL 2023
  • ADVM 2014
  • Fundamental
  • Price
  • ZJYL $0.27
  • ADVM $4.29
  • Analyst Decision
  • ZJYL
  • ADVM Buy
  • Analyst Count
  • ZJYL 0
  • ADVM 5
  • Target Price
  • ZJYL N/A
  • ADVM $16.60
  • AVG Volume (30 Days)
  • ZJYL 2.8M
  • ADVM 1.0M
  • Earning Date
  • ZJYL 08-20-2025
  • ADVM 11-07-2025
  • Dividend Yield
  • ZJYL N/A
  • ADVM N/A
  • EPS Growth
  • ZJYL N/A
  • ADVM N/A
  • EPS
  • ZJYL 0.01
  • ADVM N/A
  • Revenue
  • ZJYL $22,826,624.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • ZJYL N/A
  • ADVM $1,191.10
  • Revenue Next Year
  • ZJYL N/A
  • ADVM N/A
  • P/E Ratio
  • ZJYL $21.83
  • ADVM N/A
  • Revenue Growth
  • ZJYL 13.42
  • ADVM N/A
  • 52 Week Low
  • ZJYL $0.22
  • ADVM $1.78
  • 52 Week High
  • ZJYL $2.20
  • ADVM $8.18
  • Technical
  • Relative Strength Index (RSI)
  • ZJYL 32.63
  • ADVM 49.94
  • Support Level
  • ZJYL $0.22
  • ADVM $4.18
  • Resistance Level
  • ZJYL $0.28
  • ADVM $4.37
  • Average True Range (ATR)
  • ZJYL 0.05
  • ADVM 0.21
  • MACD
  • ZJYL 0.00
  • ADVM -0.04
  • Stochastic Oscillator
  • ZJYL 26.09
  • ADVM 48.40

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: